biote Corp. (BTMD)
(Delayed Data from NSDQ)
$5.96 USD
+0.21 (3.65%)
Updated Aug 23, 2024 03:59 PM ET
After-Market: $5.98 +0.02 (0.34%) 7:58 PM ET
3-Hold of 5 3
A Value A Growth B Momentum A VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
BTMD 5.96 +0.21(3.65%)
Will BTMD be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for BTMD based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for BTMD
Zacks.com featured highlights include Steelcase Carriage Services, biote and Acme United
Buy These 4 Stocks With Rising Cash Flows for Big Gains
BTMD: What are Zacks experts saying now?
Zacks Private Portfolio Services
Zacks.com featured highlights include Ardmore Shipping, TXO Partners, GeoPark and biote
biote Corp. (BTMD) is on the Move, Here's Why the Trend Could be Sustainable
Buy 4 Stocks With Rising Cash Flows to Enrich Your Portfolio
Other News for BTMD
Analysts Are Bullish on These Healthcare Stocks: biote (BTMD), Ardent Health Partners, Inc. (ARDT)
biote Corp. (BTMD) Q2 2024 Earnings Call Transcript
Roth MKM Keeps Their Buy Rating on biote (BTMD)
Truist Financial Gives a Buy Rating to biote (BTMD)
BIOTE reports Q2 GAAP EPS of -$0.19